Order Article Reprints

González Campos E, Grover Páez F, Ramos Becerra CG, Balleza Alejandri LR, Suárez Rico DO, Cardona Muñoz EG, Pascoe González S, Ramos Zavala MG, Beltrán Ramírez A, García Galindo JJ, et al. Empagliflozin Leads to Faster Improvement in Arterial Stiffness Compared to Dapagliflozin: A Double-Blind Clinical. Life. 2025; 15(5):802. https://doi.org/10.3390/life15050802

González Campos, Erick, Fernando Grover Páez, Carlos Gerardo Ramos Becerra, Luis Ricardo Balleza Alejandri, Daniel Osmar Suárez Rico, Ernesto Germán Cardona Muñoz, Sara Pascoe González, María Guadalupe Ramos Zavala, Alberto Beltrán Ramírez, Jesús Jonathan García Galindo, and et al. 2025. "Empagliflozin Leads to Faster Improvement in Arterial Stiffness Compared to Dapagliflozin: A Double-Blind Clinical" Life 15, no. 5: 802. https://doi.org/10.3390/life15050802

González Campos, E., Grover Páez, F., Ramos Becerra, C. G., Balleza Alejandri, L. R., Suárez Rico, D. O., Cardona Muñoz, E. G., Pascoe González, S., Ramos Zavala, M. G., Beltrán Ramírez, A., García Galindo, J. J., & Cardona Müller, D. (2025). Empagliflozin Leads to Faster Improvement in Arterial Stiffness Compared to Dapagliflozin: A Double-Blind Clinical. Life, 15(5), 802. https://doi.org/10.3390/life15050802